A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults

Grant

Date/time Interval

  • March 13, 2020 - November 30, 2021
  • Awarded By

    Total Award Amount

  • 184546.00
  • Direct Costs

  • 129005.00
  • Sponsor Award Id

  • A308004
  • Contributor

  • Jeanne Marrazzo   Investigator  
  • Nathan Erdmann   Investigator  
  • Paul Goepfert M.D.   Principal Investigator